Loading clinical trials...
Loading clinical trials...
Impact of CYP2C19 Gene Polymorphism on Long-term Major Adverse Cardiac and Vascular Events
Conditions
Locations
2
United States
UF Health
Gainesville, Florida, United States
UF Health
Jacksonville, Florida, United States
Start Date
January 1, 2011
Primary Completion Date
December 31, 2023
Completion Date
December 31, 2026
Last Updated
March 31, 2026
NCT06916520
NCT07444957
NCT07444931
NCT07107971
NCT07025148
NCT06681740
Lead Sponsor
University of Florida
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions